fluorescein-5-isothiocyanate has been researched along with Dermatitis Medicamentosa in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Connell, AJ; Fay, BL; Peel, MT; Scuron, MD; Smith, PA | 1 |
Akiyama, H; Iwatsuki, K; Morizane, S; Oono, T; Yamasaki, O | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Dermatitis Medicamentosa
Article | Year |
---|---|
Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis.
Topics: Administration, Cutaneous; Animals; Betamethasone; Clobetasol; Cytokines; Dermatitis; Disease Models, Animal; Drug Eruptions; Drug Evaluation, Preclinical; Female; Fluorescein-5-isothiocyanate; Grooming; Humans; In Vitro Techniques; Interleukin-33; Janus Kinase Inhibitors; Lymphocyte Subsets; Mice; Mice, Inbred BALB C; Mice, Transgenic; Nitriles; Ointments; Organ Culture Techniques; Pruritus; Pyrazoles; Pyrimidines; Random Allocation; Signal Transduction; Skin; Specific Pathogen-Free Organisms; T-Lymphocytes, Helper-Inducer; Thymic Stromal Lymphopoietin; Transcriptome | 2020 |
Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy.
Topics: Adolescent; Animals; Colony Count, Microbial; Concanavalin A; Croton Oil; Dermatologic Agents; Drug Eruptions; Female; Fluorescein-5-isothiocyanate; Humans; Impetigo; In Vitro Techniques; Male; Mice; Microscopy, Confocal; Streptococcal Infections; Streptococcus pyogenes | 2003 |